The Food and Drug Administration (FDA) assessed The American National Red Cross in Cleveland on March 19 to review blood and blood products, according to data available on the FDA’s website.
The inspection’s final report found that The American National Red Cross was not required to implement any corrective actions related to its management practices.
The FDA regularly inspects facilities nationwide to ensure their operations and products meet FDA laws and regulations designed to enhance public health. These inspection results are then made available to the public.
The agency’s website states that the FDA is primarily tasked with overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco product distribution and production.
Details for this article were sourced from the U.S. Food and Drug Administration. Access the data here.
